Stay updated with breaking news from John Quisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WATERTOWN, Mass., Dec. 20, 2023 -- Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients...
Substantial, dose-dependent reductions in serum hepcidin and increases in serum iron Hematologic response demonstrated by increased hemoglobin levels and reduction in transfusion burdenDISC-0974 was...
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension , today announced...
The FDA has granted Fast Track designation to MWTX-003 (DISC-3405) for the treatment of patients with polycythemia vera.
The FDA has granted fast track designation to MWTX-003 (DISC-3405) for the treatment of patients with polycythemia vera.